/
Immunology
333Diseases↗
4.6KPipeline Programs↗
1.7KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
8,265
clinical trials
Completed4,892 · 59%
Recruiting923 · 11%
Terminated738 · 9%
Unknown status608 · 7%
Not yet recruiting387 · 5%
Active, not recruiting368 · 4%
Other349 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
Systemic Lupus Erythematosus
Most programs270
Programs
664
Trials
82
Recruiting
Pre
36
P1
126
P2
114
P3
45
Appr
30
Most programs:
Roche
RocheRheumatoid Arthritis
Most trials672
Programs
119
Trials
82
Recruiting
Pre
111
P1
125
P2
296
P3
163
Appr
114
Most programs:
Pfizer
PfizerPsoriasis
Highest activity450
Programs
154
Trials
58
Recruiting
Pre
68
P1
98
P2
236
P3
136
Appr
86
Most programs:
LEO Pharma
LEO PharmaUlcerative Colitis
12381 programs166 trialsApproved
Atopic Dermatitis
8373 programs169 trialsApproved
Immunodeficiency
3232 programs41 trialsApproved
Allergic Rhinitis
2194 programs46 trialsApproved
Lupus
116 programs199 trialsApproved
Crohn's Disease
1071 programs130 trialsApproved
Systemic Sclerosis
1135 programs46 trialsApproved
Psoriatic Arthritis
1101 programs55 trialsApproved
Myasthenia Gravis
584 programs71 trialsApproved
Lupus Erythematosus
9 programs142 trialsApproved
Allergy
108 programs29 trialsApproved
Graft Versus Host Disease
288 programs33 trialsApproved
Oral Mucositis
98 programs21 trialsApproved
Alopecia Areata
484 programs35 trialsApproved
Seasonal Allergic Rhinitis
195 programs13 trialsApproved
HAE
0 programs94 trials
Mucositis
54 programs23 trialsApproved
Vasculitis
47 programs28 trialsApproved
Rheumatic Disease
51 programs20 trialsApproved
Chronic Graft Versus Host Disease
651 programs10 trialsApproved
Allergic Conjunctivitis
57 programs2 trialsApproved
Allergic Asthma
53 programs6 trialsApproved
Scleroderma
47 programs11 trialsApproved
Acute Graft Versus Host Disease
245 programs7 trialsApproved
Refractory Autoimmune Diseases
0 programs49 trialsPhase 1
Angioedema
126 programs21 trialsApproved
Chronic Granulomatous Disease
435 programs11 trialsApproved
Showing top 30 diseases by activity. 303 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)